The Budget also introduces Biopharma SHAKTI—a five-year, ₹10,000 crore programme to position India as a global hub for biopharma manufacturing by strengthening capabilities in biologics and biosimilars. https://ift.tt/hKJVZPi
Budget 2026: Deepening domestic manufacturing capabilities, expanding global reach
Reviewed by DAILY UPDATES
on
February 13, 2026
Rating: 5
No comments
PLEASE DO NOT ENTER ANY SPAM LINK IN THE COMMENT BOX
No comments
PLEASE DO NOT ENTER ANY SPAM LINK IN THE COMMENT BOX